VSPharmTech

Private

DaeguHealthcare & Life Scienceshttps://vspharmtech.com/

Last Round

Series C

Jun 1, 2026

Est. Valuation

$68.9M

Total Funding Raised

$14.4M

Company Overview

VSPharmTech is a biotechnology company that develops innovative radiosensitizer drugs designed to enhance the effectiveness of radiation therapy for various types of cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

radiosensitizeroncology therapeuticssmall-molecule drugsclinical-stage biotechdrug discoveryradiation therapyclinical trialsbiotech startupchemoradiotherapyclinical research organizationCROtechnology transferdrug pipelinecancer research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VSPharmTech Comps

Public and private peers based on sector, stage, and business model.

VSPharmTech comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

VSPharmTech Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series C	Jun 1, 2026
Series B Extension	Sep 18, 2025
Series B	Oct 1, 2023
VC Round	Apr 11, 2023
Series A	Apr 8, 2022
Seed	May 18, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

이규훈

Chief Financial Officer

Executive Team

VSPharmTech Investors

Notable investors and investment history

VSPharmTech investors
Investor	Rounds
Y&Archer	Seed, Accelerator
SL Investment	Series B
IBK Capital	Series B
Kairos Ventures	VC Round
Korea Development Bank	Series B
ST Capital (Korea)	Series A
Enlight Ventures	Seed, Series B, VC Round, Series A, Series B Extension

View all Investors

VSPharmTech Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

VSPharmTech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about VSPharmTech's valuation, stock price, and market status.

Firmographic Details

HeadquartersDaegu

Employee Range17

Year Founded2018

Last FundingJun 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.